<SEC-DOCUMENT>0001140361-16-078067-index.html : 20160829
<SEC-HEADER>0001140361-16-078067.hdr.sgml : 20160829
<ACCEPTANCE-DATETIME>20160829163131
ACCESSION NUMBER:		0001140361-16-078067
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20160829
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160829
DATE AS OF CHANGE:		20160829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OncoCyte Corp
		CENTRAL INDEX KEY:			0001642380
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				271041563
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37648
		FILM NUMBER:		161858180

	BUSINESS ADDRESS:	
		STREET 1:		1301 HARBOR BAY PARKWAY
		STREET 2:		SUITE 100
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		510-521-3390

	MAIL ADDRESS:	
		STREET 1:		1301 HARBOR BAY PARKWAY
		STREET 2:		SUITE 100
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>ONCOCYTE CORPORATION 8-K 8-29-2016
<TEXT>
Document 1 - file: form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>ex4_1.htm <DESCRIPTION>EXHIBIT 4.1 <TEXT> Document 2 - file: ex4_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>ex10_1.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 3 - file: ex10_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>ex10_2.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 4 - file: ex10_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>5 <FILENAME>ex99_1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 5 - file: ex99_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image00002.jpg <TEXT> Document 6 - file: image00002.jpg
</DOCUMENT> </SEC-DOCUMENT>